Combination treatment of parotid salivary gland cancer

Cover Page


Cite item

Full Text

Abstract

Background: Cancer of the parotid salivary gland (PSG) accounts for more than a half of all cases of salivary gland malignancies. Its treatment strategy remains a matter of debate.

Aim: To identify factors significantly associated with the 3-year survival of patients with PSG cancer after combination treatment.

Materials and methods: Thirty nine patients with morphologically confirmed PSG cancer (T1-4N0) were recruited into the study. Surgery (partial or total parotidectomy without the cervical lymphatic node dissection) was performed in 32 patients. The most frequent diagnosis (n = 10; 25.6% of all cases) was adenocarcinoma. Radiation to PSG and the regional lymphatic nodes was used in 15 patients as neoadjuvant and in 24 as adjuvant regimen. Three-year survival rates were analyzed in 36 patients by the Kaplan-Meier method, with consideration of their sex, age and the sequence of surgical and radiation treatment.

Results: The 3-year survival after combination treatment of PSG cancer patients was 82.7%. Women, patients above 60 years of age and those who received adjuvant radiation therapy demonstrated a trend towards better 3-year survival, although it was non-significant (p > 0.05).

Conclusion: Combination strategy remains an effective approach to PSG cancer irrespective of age and sex of patients. The use of radiation therapy as a single modality is possible only in exceptional cases.

About the authors

A. S. Balkanov

Moscow Regional Research and Clinical Institute (MONIKI)

Author for correspondence.
Email: andreybalkanov@yandex.ru

MD, PhD, Head of Department of Radiology

61/2–7 Shchepkina ul., Moscow, 129110, Russian Federation. Tel.: +7 (495) 681 19 07

Россия

O. A. Bychenkov

Moscow Regional Research and Clinical Institute (MONIKI)

Email: fake@neicon.ru

MD, PhD, Senior Research Fellow, Department of Radiology

61/2 Shchepkina ul., Moscow, 129110, Russian Federation

Россия

A. M. Sipkin

Moscow Regional Research and Clinical Institute (MONIKI)

Email: fake@neicon.ru

MD, PhD, Leading Research Fellow, Oral and Maxillofacial Surgery Department

61/2 Shchepkina ul., Moscow, 129110, Russian Federation

Россия

L. E. Gaganov

Moscow Regional Research and Clinical Institute (MONIKI)

Email: fake@neicon.ru

MD, PhD, Chief of Department of Pathological Anatomy

61/2 Shchepkina ul., Moscow, 129110, Russian Federation

Россия

References

  1. Taghavi N, Sargolzaei S, Mashhadiabbas F, Akbarzadeh A, Kardouni P. Salivary gland tumors: a 15-year report from Iran. Turk Patoloji Derg. 2016;32(1):35–9. doi: 10.5146/tjpath.2015.01336.
  2. Gill MS, Muzaffar S, Soomro IN, Kayani N, Hussainy AS, Pervez S, Hasan SH. Morphological pattern of salivary gland tumours. J Pak Med Assoc. 2001;51(10):343–6.
  3. Zbären P, Schüpbach J, Nuyens M, Stauffer E, Greiner R, Häusler R. Carcinoma of the parotid gland. Am J Surg. 2003;186(1):57–62. doi: http://dx.doi.org/10.1016/S0002-9610(03)00105-3.
  4. Torabinia N, Khalesi S. Clinicopathological study of 229 cases of salivary gland tumors in Isfahan population. Dent Res J (Isfahan). 2014;11(5): 559–63.
  5. Iqbal H, Bhatti AB, Hussain R, Jamshed A. Ten year experience with surgery and radiation in the management of malignant major salivary gland tumors. Asian Pac J Cancer Prev. 2014;15(5):2195–9.
  6. Bell RB, Dierks EJ, Homer L, Potter BE. Management and outcome of patients with malignant salivary gland tumors. J Oral Maxillofac Surg. 2005;63(7):917–28. doi: http://dx.doi.org/10.1016/j.joms.2005.03.006.
  7. Andreoli MT, Andreoli SM, Shrime MG, Devaiah AK. Radiotherapy in parotid acinic cell carcinoma: does it have an impact on survival? Arch Otolaryngol Head Neck Surg. 2012;138(5):463–6. doi: 10.1001/archoto.2012.226.
  8. Chen AM, Lau VH, Farwell DG, Luu Q, Donald PJ. Mucoepidermoid carcinoma of the parotid gland treated by surgery and postoperative radiation therapy: clinicopathologic correlates of outcome. Laryngoscope. 2013;123(12):3049–55. doi: 10.1002/lary.24238.
  9. Al-Mamgani A, van Rooij P, Verduijn GM, Meeuwis CA, Levendag PC. Long-term outcomes and quality of life of 186 patients with primary parotid carcinoma treated with surgery and radiotherapy at the Daniel den Hoed Cancer Center. Int J Radiat Oncol Biol Phys. 2012;84(1):189–95. doi: 10.1016/j.ijrobp.2011.11.045.
  10. Lim YC, Lee SY, Kim K, Lee JS, Koo BS, Shin HA, Choi EC. Conservative parotidectomy for the treatment of parotid cancers. Oral Oncol. 2005;41(10):1021–7. doi: 10.1016/j.oraloncology.2005.06.004.
  11. Patel S, Mourad WF, Wang C, Dhanireddy B, Concert C, Ryniak M, Khorsandi AS, Shourbaji RA, Li Z, Culliney B, Patel R, Bakst RL, Tran T, Shasha D, Schantz S, Persky MS, Hu KS, Harrison LB. Postoperative radiation therapy for parotid pleomorphic adenoma with close or positive margins: treatment outcomes and toxicities. Anticancer Res. 2014;34(8):4247–51.
  12. Garden AS, el-Naggar AK, Morrison WH, Callender DL, Ang KK, Peters LJ. Postoperative radiotherapy for malignant tumors of the parotid gland. Int J Radiat Oncol Biol Phys. 1997;37(1):79–85. doi: http://dx.doi.org/10.1016/S0360-3016(96)00464-6.
  13. Ali S, Bryant R, Palmer FL, DiLorenzo M, Shah JP, Patel SG, Ganly I. Distant Metastases in Patients with Carcinoma of the Major Salivary Glands. Ann Surg Oncol. 2015;22(12):4014–9. doi: 10.1245/s10434-015-4454-y.
  14. Toonkel LM, Guha S, Foster P, Dembrow V. Radiotherapy for parotid cancer. Ann Surg Oncol. 1994;1(6):468–72.
  15. Jegadeesh N, Liu Y, Prabhu RS, Magliocca KR, Marcus DM, Higgins KA, Vainshtein JM, Trad Wadsworth J, Beitler JJ. Outcomes and prognostic factors in modern era management of major salivary gland cancer. Oral Oncol. 2015;51(8):770–7. doi: 10.1016/j.oraloncology.2015.05.005.
  16. Kawata R, Koutetsu L, Yoshimura K, Nishikawa S, Takenaka H. Indication for elective neck
  17. dissection for N0 carcinoma of the parotid gland: a single institution's 20-year experience. Acta Otolaryngol. 2010;130(2):286–92. doi: 10.3109/00016480903062160.
  18. Armstrong JG, Harrison LB, Thaler HT, Friedlander-Klar H, Fass DE, Zelefsky MJ, Shah JP, Strong EW, Spiro RH. The indications for elective treatment of the neck in cancer of the major salivary glands. Cancer. 1992;69(3):615–9. doi: 10.1002/1097-0142(19920201)69:3<615::AID-CNCR2820690303>3.0.CO;2-9.
  19. Pastore A, Merlo R, Chiarello G, Calearo C. The problem of lymph nodes in malignant epithelial tumors of the parotid gland. Acta Otorhinolaryngol Ital. 1995;15(2):87–90.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2017 Balkanov A.S., Bychenkov O.A., Sipkin A.M., Gaganov L.E.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies